R5 Final QA

This page is part of the FHIR Specification (v5.0.0-draft-final: Final QA Preview for R5 - see ballot notes). The current version which supercedes this version is 5.0.0. For a full list of available versions, see the Directory of published versions . Page versions: R5 R4B

Example RegulatedAuthorization/basic-drug-auth (Narrative)

Biomedical Research and Regulation Work GroupMaturity Level: N/AStandards Status: InformativeCompartments: Not linked to any defined compartments

This is the narrative for the resource. See also the XML, JSON or Turtle format. This example conforms to the profile RegulatedAuthorization.

Generated Narrative: RegulatedAuthorization

Resource RegulatedAuthorization "basic-drug-auth"

subject: MedicinalProductDefinition/equilidem

type: Regulatory Drug Marketing Approval ()

status: active ([not stated]#active)

statusDate: 2016-01-01

holder: Organization/EqlidrugCo: EquiliDrugCo Holdings Inc.

regulator: Organization/FDA: FDA

 

 

Usage note: every effort has been made to ensure that the examples are correct and useful, but they are not a normative part of the specification.